Dexlansoprazole
NDC Package 24979-704-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dexlansoprazole is delayed-release capsules are contraindicated in patients with known hypersensitivity to any component of the formulation [see Description (11)]. Marketed by Twi Pharmaceuticals, Inc., this product is identified by NDC 24979-704 and is authorized under FDA application NDA022287.

Identification & Billing

NDC Package Code
24979-704-07
Package Description
90 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Product Code
24979-704
11-Digit Billing Format
24979070407
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA
RxNorm Crosswalk
  • RxCUI: 833204 - dexlansoprazole 30 MG Delayed Release Oral Capsule
  • RxCUI: 833213 - dexlansoprazole 60 MG Delayed Release Oral Capsule

Clinical Specifications

Proprietary Name
Dexlansoprazole Delayed Release
Dosage Form
-
Usage Information
Dexlansoprazole delayed-release capsules are contraindicated in patients with known hypersensitivity to any component of the formulation [see Description (11)]. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis and urticaria [see Warnings and Precautions (5.2), Adverse Reactions (6)].PPIs, including dexlansoprazole, are contraindicated with rilpivirine-containing products [see Drug Interactions (7)].

Regulatory & Marketing

Labeler Name
Twi Pharmaceuticals, Inc.
FDA Application #
NDA022287
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
01-01-2022
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24979-704). Click a package code to view its specific billing and regulatory data.

24979-704-06
30 CAPSULE, DELAYED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24979-704-07 identifies a specific commercial package of 90 capsule, delayed release in 1 bottle of Dexlansoprazole Delayed Release, labeled by Twi Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Twi Pharmaceuticals, Inc. on January 01, 2022. The current certification is valid through December 31, 2025.

How is this Twi Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24979070407. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24979-704-07
11-Digit CMS (5-4-2)
24979-0704-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.